Biopharmaceuticals
Regulatory
News Release - September 20, 2013
RELVAR(TM) ELLIPTA(TM) Gains Approval in Japan for the Treatment of Asthma
Source: Theravance
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.